Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

DC-SIGN/CD209 Antikörper (FITC)

Der Maus Monoklonal Anti-DC-SIGN/CD209-Antikörper wurde für FACS und Func validiert. Er ist geeignet, DC-SIGN/CD209 in Proben von Human zu detektieren.
Produktnummer ABIN1106054

Kurzübersicht für DC-SIGN/CD209 Antikörper (FITC) (ABIN1106054)

Target

Alle DC-SIGN/CD209 (CD209) Antikörper anzeigen
DC-SIGN/CD209 (CD209) (CD209)

Reaktivität

  • 125
  • 27
  • 21
  • 1
  • 1
Human

Wirt

  • 79
  • 58
  • 4
  • 1
  • 1
  • 1
Maus

Klonalität

  • 72
  • 72
Monoklonal

Konjugat

  • 64
  • 10
  • 9
  • 7
  • 7
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser DC-SIGN/CD209 Antikörper ist konjugiert mit FITC

Applikation

  • 73
  • 55
  • 51
  • 32
  • 27
  • 19
  • 13
  • 8
  • 7
  • 6
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Functional Studies (Func)

Klon

DCN47-5
  • Spezifität

    This antibody reacts with the C-type lectin, DC-SIGN (CD209), exclusively expressed on human dendritic cells (DC).

    Kreuzreaktivität (Details)

    Species reactivity (tested):Human

    Aufreinigung

    Protein G

    Isotyp

    IgG1
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    0.1 mg/mL

    Buffer

    PBS, 0.02 % sodium azide, 1 % bovine serum albumin

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C

    Informationen zur Lagerung

    Store at 2 - 8 °C.
  • Target

    DC-SIGN/CD209 (CD209) (CD209)

    Andere Bezeichnung

    CD209 / DC-SIGN

    Hintergrund

    DC are specialized antigen presenting cells and bridge the innate and the adaptive immune system. They provide high levels of costimulation necessary for activation of both naive and antigen-experienced T-cells. Immature DC are capable to migrate to inflammatory sites, capture antigen and process it internally to form MHC-peptide complexes. Following antigen uptake, DC undergo maturation and migrate to lymphoid organs where they can present MHC-peptide complexes to resting T-cells and drive T-cell proliferation. During differentiation and maturation of DC, several phenotypic surface markers are expressed: CD1a, CD4, CD11, CD40, CD86, and HLA-DR. Immature DC predominantly express CCR5 which enables DC to migrate to inflammatory sites, whereas mature DC express high levels of CXCR4, a receptor that facilitates migration to lymphoid organs.DC also express DC-specific, ICAM-3 grabbing, nonintegrin (DC-SIGN), a 44 kDa C-type lectin that binds to the HIV-1 envelope glycoprotein gp120, ICAM-3 on T-cells and ICAM-2 on endothelial cells. HIV virions are able to infect cells expressing CD4 and the chemokine co-receptors CCR5 or CXCR4 and can attach to DC-SIGN to extend virion lifespan. Therefore, DC are candidates for HIV-1 infection. DC-SIGN-ICAM-3 binding is integrin-independent but calcium-dependent and antibodies reactive against DC-SIGN can be used to study DC-SIGN-ICAM3 binding.Synonyms: C-type lectin domain family 4 member L, CLEC4L, DC-SIGN1, DCSIGN, DCSIGN1, Dendritic Cell Marker, Dendritic cell-specific ICAM-3-grabbing non-integrin 1

    UniProt

    Q9NNX6
Sie sind hier:
Chat with us!